513 related articles for article (PubMed ID: 34301257)
1. Higher long-term visit-to-visit glycemic variability predicts new-onset atrial fibrillation in patients with diabetes mellitus.
Hsu JC; Yang YY; Chuang SL; Yu CC; Lin LY
Cardiovasc Diabetol; 2021 Jul; 20(1):148. PubMed ID: 34301257
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Visit-to-Visit Glycemic Variability as a Predictor of Major Adverse Limb and Cardiovascular Events in Patients With Diabetes.
Hsu JC; Yang YY; Chuang SL; Huang KC; Lee JK; Lin LY
J Am Heart Assoc; 2023 Feb; 12(3):e025438. PubMed ID: 36695326
[TBL] [Abstract][Full Text] [Related]
3. Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study.
Hsu JC; Huang YT; Lin LY
Aging (Albany NY); 2020 Nov; 12(23):24219-24227. PubMed ID: 33226371
[TBL] [Abstract][Full Text] [Related]
4. Underweight is a major risk factor for atrial fibrillation in Asian people with type 2 diabetes mellitus.
Hsu JC; Yang YY; Chuang SL; Chung YW; Wang CH; Lin LY
Cardiovasc Diabetol; 2021 Nov; 20(1):226. PubMed ID: 34819090
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of diabetes mellitus in patients with atrial fibrillation.
Papazoglou AS; Kartas A; Samaras A; Vouloagkas I; Vrana E; Moysidis DV; Akrivos E; Kotzampasis G; Baroutidou A; Papanastasiou A; Liampas E; Botis M; Karagiannidis E; Stalikas N; Karvounis H; Tzikas A; Giannakoulas G
Cardiovasc Diabetol; 2021 Feb; 20(1):40. PubMed ID: 33573666
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Dipeptidyl Peptidase-4 Inhibitor on the Risks of New-Onset Atrial Fibrillation, Stroke and Mortality in Diabetic Patients: A Propensity Score-Matched Study in Hong Kong.
Lee S; Zhou J; Leung KSK; Wai AKC; Jeevaratnam K; King E; Liu T; Wong WT; Chang C; Wong ICK; Cheung BMY; Tse G; Zhang Q
Cardiovasc Drugs Ther; 2023 Jun; 37(3):561-569. PubMed ID: 35142921
[TBL] [Abstract][Full Text] [Related]
7. Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation.
Chan YH; Chuang C; Chan CC; Lee HF; Huang YC; Huang YT; Chang SH; Wang CL; Chao TF; Kuo CT; Yeh YH; Chen SA
Cardiovasc Diabetol; 2020 Mar; 19(1):30. PubMed ID: 32156277
[TBL] [Abstract][Full Text] [Related]
8. Prediabetes as a risk factor for new-onset atrial fibrillation: the propensity-score matching cohort analyzed using the Cox regression model coupled with the random survival forest.
Hsu JC; Yang YY; Chuang SL; Lin LY; Chen TH
Cardiovasc Diabetol; 2023 Feb; 22(1):35. PubMed ID: 36804876
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of modifiable risk factors and relation to stroke and death in patients with atrial fibrillation: A report from the China atrial fibrillation registry study.
Jiang C; Lan DH; Du X; Geng YP; Chang SS; Zheng D; Chen JB; Yu RH; Sang CH; Long DY; Tang RB; Zhou YC; Min Y; Lu Y; Dong JZ; Lip GYH; Ma CS
J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2759-2766. PubMed ID: 31599040
[TBL] [Abstract][Full Text] [Related]
10. Glycated hemoglobin and risk of first episode stroke in diabetic patients with atrial fibrillation: A cohort study.
Saliba W; Barnett-Griness O; Elias M; Rennert G
Heart Rhythm; 2015 May; 12(5):886-92. PubMed ID: 25614249
[TBL] [Abstract][Full Text] [Related]
11. Incidence of ischemic stroke or transient ischemic attack in patients with multiple risk factors with or without atrial fibrillation: a retrospective cohort study.
Yuan Z; Makadia R; Ryan P; Yannicelli D; Nessel C; Sarich T
Curr Med Res Opin; 2015; 31(7):1257-66. PubMed ID: 25877807
[TBL] [Abstract][Full Text] [Related]
12. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
13. Prior stroke and transient ischemic attack as risk factors for subsequent stroke in atrial fibrillation patients: A report from the GARFIELD-AF registry.
Hacke W; Bassand JP; Virdone S; Camm AJ; Fitzmaurice DA; Fox KA; Goldhaber SZ; Goto S; Haas S; Kayani G; Mantovani LG; Misselwitz F; Pieper KS; Turpie AG; van Eickels M; Verheugt FW; Kakkar AK;
Int J Stroke; 2020 Apr; 15(3):308-317. PubMed ID: 31847794
[TBL] [Abstract][Full Text] [Related]
14. Impact of long-term glycemic variability on development of atrial fibrillation in type 2 diabetic patients.
Gu J; Fan YQ; Zhang JF; Wang CQ
Anatol J Cardiol; 2017 Dec; 18(6):410-416. PubMed ID: 29256876
[TBL] [Abstract][Full Text] [Related]
15. Ischemic Stroke and Transient Ischemic Attack Risk Following Vitamin K Antagonist Cessation in Newly Diagnosed Atrial Fibrillation: A Cohort Study.
Martinez C; Wallenhorst C; Rietbrock S; Freedman B
J Am Heart Assoc; 2020 Jan; 9(2):e014376. PubMed ID: 31937194
[TBL] [Abstract][Full Text] [Related]
16. Associations of combined polygenic risk score and glycemic status with atrial fibrillation, coronary artery disease and ischemic stroke.
Kim J; Kim D; Bae HJ; Park BE; Kang TS; Lim SH; Lee SY; Chung YH; Ryu JW; Lee MY; Yang PS; Joung B
Cardiovasc Diabetol; 2024 Jan; 23(1):5. PubMed ID: 38172896
[TBL] [Abstract][Full Text] [Related]
17. Association of New-Onset Atrial Fibrillation After Noncardiac Surgery With Subsequent Stroke and Transient Ischemic Attack.
Siontis KC; Gersh BJ; Weston SA; Jiang R; Kashou AH; Roger VL; Noseworthy PA; Chamberlain AM
JAMA; 2020 Sep; 324(9):871-878. PubMed ID: 32870297
[TBL] [Abstract][Full Text] [Related]
18. The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden.
Boriani G; Lip GYH; Ricci RP; Proclemer A; Landolina M; Lunati M; Padeletti L; Zanotto G; Molon G; Biffi M; Rordorf R; Quartieri F; Gasparini M
Europace; 2017 Nov; 19(11):1767-1775. PubMed ID: 28031277
[TBL] [Abstract][Full Text] [Related]
19. Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study).
Fatemi O; Yuriditsky E; Tsioufis C; Tsachris D; Morgan T; Basile J; Bigger T; Cushman W; Goff D; Soliman EZ; Thomas A; Papademetriou V
Am J Cardiol; 2014 Oct; 114(8):1217-22. PubMed ID: 25159234
[TBL] [Abstract][Full Text] [Related]
20. Visit-to-visit variability of fasting plasma glucose as predictor of ischemic stroke: competing risk analysis in a national cohort of Taiwan Diabetes Study.
Lin CC; Yang CP; Li CI; Liu CS; Chen CC; Lin WY; Hwang KL; Yang SY; Li TC
BMC Med; 2014 Sep; 12():165. PubMed ID: 25255837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
